z-logo
Premium
Activity of Various Growth Substances in the Avena First Internode Test
Author(s) -
JUNTTILA OLAVI,
HEIDE OLA M.
Publication year - 1973
Publication title -
physiologia plantarum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.351
H-Index - 146
eISSN - 1399-3054
pISSN - 0031-9317
DOI - 10.1111/j.1399-3054.1973.tb04840.x
Subject(s) - abscisic acid , kinetin , avena , gibberellin , elongation , chemistry , auxin , gibberellic acid , plant growth , cytokinin , botany , horticulture , stereochemistry , biochemistry , biology , germination , tissue culture , in vitro , materials science , gene , ultimate tensile strength , metallurgy
The elongation growth of the Avena first internode segments was studied in the presence of one or several of the following growth substances: indoleacetic acid (IAA), 6‐fur‐furylamino purine (FAP, kinetin), 6‐benzylamino purine (BAP), gibberellin A 3 (GA 3 ) and A 4+7 (GA 4+7 ), and abscisic acid (ABA). The cytokinins at concentrations of 10 −7 to 10 −6 M stimulated growth with 4 to 6 per cent but this effect was not statistically significant. Concentrations higher than 5 × 10 −6 M inhibited growth. FAP and BAP (from 10 −8 M to 10 −6 M ) had no significant interaction with any other growth substance used. The two‐factor interactions of IAA × ABA, IAA × GA 3 , and GA 3 × ABA, as well as the three‐factor interaction IAA × ABA × GA 3 were significant. However, the IAA × ABA interaction was significant only when high concentration (10 −6 M ) of ABA was used. The growth inhibition produced by 10 −7 and 10 −6 M ABA was overcome by about equimolar concentrations of IAA. The stimulation of growth by GA 3 and GA 4+7 (10 −9 to 10 −7 M ) was prevented by simultaneous application of ABA, and it was reduced significantly by application of IAA (10 −7 to 10 −8 M ). GA3 at 10 −8 M combined with different concentrations of IAA gave slightly higher elongation than IAA alone but the observed values were significantly lower than expected assuming independent additive action.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here